Editas Medicine CEO steps down


Katrine Bosley, Editas Medicine’s (EDIT) CEO, has made a “personal decision” to step down according to a company spokeswoman. Cristi Barnett sent an emailed statement to Bloomberg which also announced that Bosley was resigning from the board. In the statement, Barnett said that the move was “occurring at a natural transition point for the company and also from a position of strength.” The pharmaceutical company’s shares have plummeted to $20.64, a 21% fall, in morning trading.